-
Mashup Score: 4
At the core, our devices focus on dermatologic conditions, requiring more effective therapeutic options and more acceptable to patient standards and levels of safety. Aerolase develops scalable, leading-edge devices for forward-thinking medical professionals who want to deliver top-of-the-line therapies, immeasurable patient experiences, and incredible patient results for all things skin-related. We develop lasers with everything you need to take your work to the next level power, capability, and
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 3Journal Digest: May 3 - 2 day(s) ago
This week’s collection of the latest dermatologic studies includes social determinants of health in HS, JNJ-77242113 for moderate to severe plaque psoriasis, sonidegib for locally advanced and metastatic BCC, and pembrolizumab in combination with chemoradiotherapy for locally advanced HNSCC.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1QUIZ: Melanoma Classification and Staging - 2 day(s) ago
Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month and Melanoma Monday.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 2Alpha Tau to Conduct Trial of Alpha DaRT Technology In Patients With Recurrent Squamous Cell Carcinoma - 2 day(s) ago
Robert Den, MD, and Alpha Tau are seeking motivated investigators who may be interested in participating in the trial.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 2Recognizing Melanoma and Skin Cancer Awareness Month - 2 day(s) ago
Our May issue of Dermatology Times spotlights melanoma/skin cancer awareness and more.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 5Navigating Plaque Psoriasis Progress: A Year in Review - 3 day(s) ago
Experts in dermatology provide a comprehensive year in review regarding the management of plaque psoriasis, highlighting key therapeutic approvals from 2023. The discussion will highlight pivotal clinical studies supporting these approvals and our discussion will then pivot to have a special focus on addressing the unique challenges faced by treating patients with skin of color and treatment access barriers.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet-
Explore the expert discussion on navigating plaque psoriasis treatment. Mark Lebwohl, MD, and Saakshi Khattri, MD, provide insights into key therapeutic approvals from 2023 and address the unique challenges faced by patients with skin of color. Watch here: https://t.co/5HedO8zfXg https://t.co/CqbRaczrc3
-
-
Mashup Score: 4
Earlier this week, we shared our fourth and final Rosacea Awareness Month quiz. Review the answers and your responses below.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 1
May is Mental Health Awareness Month, and Dermatology Times is spotlighting the common relationship between skin conditions and struggles with mental health, quality of life, and well-being.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 2The Mechanisms of Action of AD Treatments - 5 day(s) ago
Raj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, comment on the newer treatments in AD, highlighting the positive impact these agents have had in managing the disease.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
-
Mashup Score: 7JAK Inhibitors Show Favorable Risk-Benefit Profile In Vitiligo, Especially for Facial Cases - 5 day(s) ago
A new review highlighted JAK inhibitors’ role in vitiligo treatment, emphasizing varying benefits, facial efficacy, and potential for sustained responses.
Source: www.dermatologytimes.comCategories: General Medicine News, DermatologyTweet
#ad Dermatology experts discuss different devices, the adjustable features of each, the efficacy for all skin conditions, and the improved patient experience with faster results and less discomfort. Learn more: https://t.co/byGmAOcpsL https://t.co/2RPfdakRBH